Inherent abnormalities in energy metabolism in Alzheimer disease: Interaction with cerebrovascular compromise

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 204-221

  Blass, John P ^a   Sheu, Rex Kwan Fu ^a   Gibson, Gary E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; FREE RADICAL; GLUCOSE; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE;

ALZHEIMER DISEASE; BRAIN METABOLISM; CONFERENCE PAPER; ENERGY METABOLISM; GENETIC VARIABILITY; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; METABOLIC RATE; MITOCHONDRIAL RESPIRATION;

EID: 0034103586     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06370.x     Document Type: Conference Paper

References (126)

1. 1. TUCKER, G.J., M. POPKIN, E.D. CAINE, M. FOLSTEIN, G.L. GOTTLIEB, I. GRANT & B. LIPTZIN. 1993. Dementia. In DSM-IV (Diagnostic and Statistical Manual of Mental Disorders), 4th edit. American Psychiatric Association.: 133-155. Washington, DC.
2. 2. ERKINJUNTTI, T., T. OSTBYE, R. STEENHUIS & V. HACHINSKI. 1997. The effect of different diagnostic criteria on the prevalence of dementia. N. Engl. J. Med. 337: 1667-1674.
3. 3. NOLAN, K.A., M.M. LINO, A.W. SELIGMANN & J.P. BLASS. 1998. Absence of vascular dementia in an autopsy series from a dementia clinic. J. Am. Geriatr. Soc. 46: 597-604.
4. 4. BLASS, J.P. 1993. Pathophysiology of the Alzheimer's syndrome. Neurology 43(Suppl. 4): S25-S38.
5. 5. BLASS, J.P. 1996. Alzheimer's disease: melting pot or mosaic? Alzheimer's Dis. Rev. 1: 17-20.
6. 6. WALLIN, A. & K. BLENNOW. 1996. Clinical subtypes of the Alzheimer syndrome. Acta Neurol. Scand. Suppl. 165: 51-57.
7. 7. LOPEZ-ALBEROLA, R.F., W.W. BARKER, D.G. HARWOOD, D.A. LOWEWENSTEIN, P.H. ST. GEORGE-HYSLOP, T. TSUDA, E.A. ROGAEVA & R. DUARA. 1997. Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's disease. J. Geriatr. Psych. Neurol. 10: 1-6.
8. 8. DAW, E.W., S.C. HEATH & E.M. WIJSMAN. 1999. Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees. Am. J. Hum. Genet. 64: 839-851.
9. 9. HARWOOD, D.G., W.W. BARKER, D.A. LOEWENSTEIN, R.L. OWNBY, P. ST. GEORGE-HYSLOP, M. MULLAN & R. DUARA. 1999. A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology 52: 551-556.
10. 10. EDELBERG, H.K. & J.Y. WEI. 1996. The biology of Alzheimer's Disease. Mech. Ageing Dev. 91: 95-114.
11. 11. BLASS, J.P. & F.H. MCDOWELL, Eds. 1999. Mitochondrial/Energy Metabolism in Neurodegenerative Disorders. Ann. N.Y. Acad. Sci., vol. 893.
12. 12. BICK, K., L. AMADUCCI & G. PEPEU. 1987. The Early Story of Alzheimer's Disease. Lavinia Press. Padua, Italy.
13. 13. SOKOLOFF, L. 1989. Circulation and energy metabolism of the brain. In Basic Neurochemistry, 4th edit. G. Siegel, B. Agranoff, R.W. Albers & P. Molinoff, Eds.: 565-590. Raven Press. New York.
14. 14. BARCLAY, L., A. ZEMCOV, J.P. BLASS & F. MCDOWELL. 1984. Rates of decrease of cerebral blood flow in progressive dementias. Neurology 34: 1555-1560.
15. 15. PIETRINI, P., M.L. FUREY, G.E. ALEXANDER, M.J. MENTIS, A. DANI, M. GUAZZELLI, S.I. RAPOPORT & M.B. SCHAPIRO. 1999. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. Am. J. Psychol. 156: 470-473.
16. 16. SMALL, S.A., G.M. PERERA, R. DELAPAZ, R. MAYEUX & Y. STERN. 1999. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 45: 466-472.
17. 17. MURPHY, D.G.M., P.A. BOTTOMLEY, J.A. SALERNO, C. DECARLI, M.J. MENTIS, C.L. GRADY, D. TEICHBERG, K.R. GIACOMETTI, J.M. ROSENBERG, C.J. HARDY, M.B. SCHAPIRO, S.I. RAPOPORT, J.R. ALGER & B. HORWITZ. 1993. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch. Gen. Psychol. 50: 341-349.
18. 18. BLASS, J.P. 1997. Cerebral metabolic impairments. In Alzheimer's Disease: Cause(s), Diagnosis, Treatment, and Care. Z.S. Khachaturian & T.S. Radebaugh, Eds.: 187-206. CRC Press. Boca Raton, FL.
19. 19. IBÁÑEZ, V., P. PIETRINI, G.E. ALEXANDER, M.L. FUREY, M.S. TEICHBERG, J.C. RAJAPAKSE, S.I. RAPOPORT, M.D. SCHAPIRO & B. HORWITZ. 1998. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50: 1585-1593.
20. 20. SMALL, G.W., J.C. MAZZIOTTA, M.T. COLLINS, L.R. BAXTER, M.E. PHELPS, M.A. MANDELKERN, A. KAPLAN, A. LARUE, C.F. ADAMSON, L. CHANG, B.H. GUZE, E.H. CORDER, A.M. SAUNDERS, J.L. HAINES, M.A. PERICAK-VANCE & A.D. ROSES. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. J. Am. Med. Assoc. 273: 942-947.
21. 21. KENNEDY, A.M., R.S.J. FRACKOWIAK, S.K. NEWMAN, P.M. BLOOMFIELD, J. SEAWARD, P. ROQUES, G. LEWINGTON, V.J. CUNNINGHAM & M.N. ROSSER. 1995. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186: 17-20.
22. 22. REIMAN, E.M., R.J. CASELLI, L.S. YUN, K. CHEN, D. BANDY, S. MINOSHIA, S.N. THIBODEAY & D. OSBORNE. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the 4 allele for apolipoprotein E. N. Engl. J. Med. 334: 752-758.
23. 23. WHITE, H., C. PIEPER, K. SCHMADER & G. FILLENBAUM. 1996. Weight change in Alzheimer's disease. J. Am. Geriatr. Soc. 44: 265-272.
24. 24. WOLF-KLEIN, G.P. & F.A. SILVERSTONE. 1994. Weight loss in Alzheimer's disease: an international review of the literature. Int. Psychogeriatr. 6: 135-142.
25. 25. TARIOT, P.N., M.A. OGDEN, C. Cox & T. F. WILLIAMS. 1999. Diabetes and dementia in long-term care. J. Am. Geriatr. Soc. 47: 423-429.
26. 26. ADOLFSSON, R., G. BUCHT, F. LITHNER & B. WINBLAD. 1980. Hypoglycemia in Alzheimer's disease. Acta Med. Scand. 208: 387-388.
27. 27. MENEILLY, G.S. & A. HILL. 1993. Alterations in glucose metabolism in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 41: 710-714.
28. 28. DONALDSON, K.E., W.H. CARPENTER, M.J. TOTH, M.I. GORAN, P. NEWHOUSE & E.T. POEHLMAN. 1996. No evidence for a higher resting metabolic rate in noninstitutionalized Alzheimer's disease patients. J. Am. Geriatr. Soc. 44: 1232-1234.
29. 29. GIBSON, G.E., K.-F.R. SHEU & J.P. BLASS. 1998. Abnormalities in mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 105: 855-870.
30. 2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 112: 338-342.
31. 31. BOWEN, D.M., P. WHITE, J.A. SPILLANE, M.J. GOODHARDT, G. CURZON, P. IWANGOFF, W. MEIER-RUGE & A.N. DAVISON. 1979. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1: 11-14.
32. 32. SIMS, N.R., J.P. BLASS, C. MURPHY, D.M. BOWEN & D. NEARY. 1987. Phosphofructokinase activity in the brain in Alzheimer's disease. Ann. Neurol. 21: 509-510.
33. 33. PERRY, E.K., R.H. PERRY, B.E. TOMLINSON, G. BLESSED & P.H. GIBSON. 1980. Coenzyme-A acetylating enzymes in Alzheimer's disease: possible cholinergic "compartment" of pyruvate dehydrogenase. Neurosci. Lett. 18: 105-108.
34. 34. SHEU, K.-F.R., Y.-Y. KIM, J.P. BLASS & M.E. WEKSLER. 1985. An immunochemical study on the deficit of pyruvate dehydrogenase in Alzheimer's disease. Ann. Neurol. 17: 444-451.
35. 35. BUTTERWORTH, R. & A.M. BESNARD. 1990. Thiamin-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab. Brain Dis. 4: 179-182.
36. 36. YATES, C.M., M. BUTTERWORTH, M.C. TENNANT & A. GORDON. 1991. Enzyme activities in relation to pH and lactale in post-mortem brain in Alzheimer and other dementias. J. Neurochem. 55: 1624-1631.
37. 37. GIBSON, G.E., K.-F.R. SHEU, J.P. BLASS, A. BAKER, K.C. CARLSON, B. HARDING & P. PERRINO. 1988. Reduced activities of thiamin-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 35: 312-317.
38. 38. MASTROGIACOMO, F., C. BERGERON & S.J. KISH. 1993. Brain-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J. Neurochem. 61: 2007-2011.
39. 39. TERWEL, D., J. BOTHMER, E. WOLF, F. MENG & J. JOLLES. 1998. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J. Neurol. Sci. 161: 47-56.
40. 40. SCHAPIRA, A.H. 1996. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9: 260-264.
41. 41. MUTSIYAMA, E.M., A.C. BOWLING & M.F. BEAL. 1994. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63: 2179-2184.
42. 42. PARKER, W.D., J. PARKS, C.M. FILLEY & B.K. KLEINSCHMIDT-DEMASTERS. 1994. Electron transport chain defects in Alzheimer's disease brain. Neurology 44: 1090-1096.
43. 43. WONG-RILEY, M., P. ANTUONO, K.C. HO, R. EGAN, R. HEVNER, W. LIEBL, Z. HUANG, R. RACHEL & J. JONES. 1997. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res. 37: 3593-3608.
44. 44. KISH, S.J., F. MASTROGIACOMO, M. GUTTMAN, Y. FURUKAWA, J.W. TAANMAN, S. DOZIC, M. PANDOLFO, J. LAMARCHE, L. DISTEFANO & L.J. CHANG. 1999. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar disorders: a nonspecific change? J. Neurochem. 72: 700-707.
45. 45. CAVELIER, L., E.E. JAZIN, I. ERIKSSON, J. PRINCE, U. BAVE, L. ORELAND, & U. GYLLENSTEN. 1995. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29: 217-224.
46. 46. COOPER, J.M., C. WISCHIK & A.H.V. SCHAPIRA. 1993. Mitochondrial function in Alzheimer's disease. Lancet 341: 969-970.
47. 47. HEVNER, R.F. & M.T.T. WONG-RILEY. 1993. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13: 1805-1819.
48. 48. SIMONIAN, N.A. & B.T. HYMAN. 1995. Functional alterations in neural circuits in Alzheimer's disease. Neurobiol. Aging 16: 305-309.
49. 49. HATANPAA, K., D.R. BRADY, J. STOLL, S.I. RAPOPORT & K. CHANDRASEKARAN. 1996. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 40: 411-420.
50. 50. DAVIS, R.E., S. MILLER, C. HERRNSTADT, S.S. GHOSH, E. FAHY, M.F. BEAL, N. HOWELL & W.D. PARKER. 1997. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 4526-4531.
51. 51. DAVIS, R.E. & W.D. PARKER. 1998. Evidence that two reports of mtDNA cytochrome oxidase "mutations" in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin. Biochem. Biophys. Res. Commun. 244: 877-883.
52. 52. HIRANO, M., A. SHTILBANS, R. MAYEUX, M.M. DAVIDSON, S. DIMAURO, J.A. KNOWLES & E.A. SCHON. 1997. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc. Natl. Acad. Sci. USA 94: 14894-14899.
53. 53. WALLACE, D.C., C. STUGARD, D. MURDOCK, T. SCHURR & M.D. BROWN. 1997. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc. Natl. Acad. Sci. USA 94: 14900-14905.
54. 54. CASSARINO, D.S., R.H. SWERDLOW, J.K. PARKS, W.D. PARKER & J.P. BENNETT. 1998. Cyclosporin A increases resting mitochondrial membrane potential in SYSY cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Commun. 248: 168-173.
55. 55. SHEEHAN, J.P., R.H. SWERDLOW, S.W. MILLER, R.E. DAVIS, J. PARKS, W.D. PARKER & J.B. TUTTLE. 1997. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17: 4612-4622.
56. 56. SCHON, E.A., E.A. SHOUBRIDGE & C.T. MORAES. 1998. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 51: 326.
57. 57. ITO, S., S. OHTA, K. NISHIMAKI, Y. KAGAWA, R. SOMA, S.Y. KUNO, Y. KOMATSUZAKI, H. MIZUSAWA & J. HAYASHI. 1999. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96: 2099-2103.
58. 58. SWERDLOW, R.H., J.K. PARKS, S.W. MILLER, J.B. TUTTLE, P.A. TRIMMER, J.P. SHEEHAN, J.P. BENNET, R.E. DAVIS & W.D. PARKER. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40: 663-671.
59. 59. GU, M., J.M. COOPER, J.W. TAANMAN & A.H. SCHAPIRA. 1998. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44: 177-186.
60. 60. BLASS, J.P. 1993. Metabolic alterations common to neural and non-neural cells in Alzheimer's disease. Hippocampus 3: 45-54.
61. 61. BLASS, J.P., K.-FR. SHEU & L. KO. 1993. Chemical neuroanatomy and selective vulnerability in relation to disorders of energy metabolism. J. Neurochem. 61: S249.
62. 62. HUANG, H.-M., R. MARTINS, S. GANDY, R. ETCHEBERRIGARATY, E. ITO, D.L. ALKON, J.P. BLASS & G.E. GIBSON. 1995. Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 747: 225-244.
63. 63. SHEU, K.-F.R., A.J.L. COOPER, J.G. LINDSAY & J.P. BLASS. 1994. Abnormality of the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35: 312-318.
64. 64. BLASS, J.P., K.-F.R. SHEU, S. PIACENTINI & S. SORBI. 1997. Inherent abnormalities in oxidative metabolism in AD: interaction with vascular abnormalities. Ann. N.Y. Acad. Sci. 826: 382-385.
65. 65. GIBSON, G.E., H. ZHANG, K.F. SHEU, N. BOGDANOVICH, J.G. LINDSAY, L. LANNFELT, M. VESTLING & R.F. COWBURN. 1998. Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann. Neurol. 44: 676-681.
66. 66. CURTI, D., F. ROGONI, L. GASPARINI, A. CATTANEO, M. PAOLILLO, M. RACCHI, L. ZANI, A. BIANCHETTI, M. TRABUCCHI, S. BERGAMASCHI & S. GOVONI. 1997. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease patients. Neurosci. Lett. 236: 13-16.
67. 67. SIMS, N.R., J.M. FINEGAN & J.P. BLASS. 1987. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann. Neurol. 21: 509-510.
68. 68. PETERSON, C. & J.E. GOLDMAN. 1986. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA 83: 2758-2762.
69. 69. COOPER, A.J.L., K.-F.R. SHEU & J.P. BLASS. 1996. Normal glutamate metabolism in Alzheimer's disease fibroblasts deficient in α-ketoglutarate dehydrogenase activity. Dev. Neurosci. 18: 499-504.
70. 70. PARKER, W.D., N.J. MAHR, C.M. FILLEY, J.K. PARKS, D. HUGHES, D.A. YOUNG & C.M. CULLUM. 1994. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44: 1086-1090.
71. 71. VAN ZUYLEN, A.J., G.J. BOSMAN, W. RUITENBEEK, P.J. VAN KALMTHOUT & W.J. DE GRIP. 1992. No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology 42: 1246-1247.
72. 72. ADOLFSSON, R., C.-G GOTTFRIES, L. ORELAND, A. WIBERG & B. WINBLAD. 1980. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 27: 1029-1034.
73. 73. ALEXOPOULOS, G.S., R.C. YOUNG, K.W. LIEBERMAN & C.A. SHAMOIAN. 1987. Platelet MAO activity in geriatric patients with depression and dementia. Am. J. Psychiatr. 144: 1480-1483.
74. 74. BONGIOVANNI, P., F. GEMIGNANI, B. BOCCARDI, M. BORGNA & B. ROSSI. 1997. Platelet monoamine oxidase molecular activity in demented patients. Ital. J. Neurol. Sci. 18: 151-156.
75. 75. GIBSON, G.E., H. ZHANG, K.F. SHEU, N. BOGDANOVICH, J.G. LINDSAY, L. LANNFELT, M. VESTLING & R.F. COWBURN. 1998. α-Ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann. Neurol. 44: 676-681.
76. 76. GIBSON, G.E., V. HAROUTUNIAN, L.C.H. PARK, H. ZHANG, R. MOHS, R.K.F. SHEU & J.P. BLASS. 1999. Reductions in a key mitochondrial enzyme in brains from Alzheimer's correlate with a clinical dementia rating. J. Neurochem. 73: S23.
77. 77. PARK, L.C.H., H. ZHANG, R.K.-F. SHEU, N.Y. CALINGSAN, B.S. KRISTAL, J.G. LINDSAY & G.E. GIBSON. 1999. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem. 72: 1948-1958.
78. 78. CHINOPOULOS, C., L. TRETTER & V. ADAM-VIZI. 1999. Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of α-ketoglutarate dehydrogenase. J. Neurochem. 73: 220-228.
79. 79. HUMPHRIES, K.M. & L.I. SZWEDA. 1998. Selective inactivation of α-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37: 15835-15841.
80. 80. ALI, G., W. WASCO, X. CAI, P. SZABO, K.-F. SHEU, A.J. COOPER, S.M. GASTON, J.F. GUSELLA, R. TANZI & J.P. BLASS. 1994. Isolation, cloning, and localization of the gene for the E2k component of the human ketoglutarate dehydrogenase complex. Somatic Cell Mol. Genet. 20: 190-199.
81. 81. NAKANO, K., C. TAKASE, K. NISHIMAKI, T. MIKI & S. MATUDA. 1997. Alzheimer's disease and DLST genotype. Lancet 350: 1367-1368.
82. 82. CAI, X., P. SZABO, G. ALI, R.F. TANZI & J.P. BLASS. 1994. A pseudogene of dihydrolipyl succinyltransferase (E2k) found by PCR amplification and direct sequencing of rodent-human cell hybrid DNAs. Somatic Cell Mol. Genet. 20: 339-343.
83. 83. SHEU, K.-F.R., A.M. BROWN, V. HAROUTUNIAN, B.S. KRISTAL, H. THALER, M. LESSER, R. N. KALARIA, N.R. RELKIN, R.C. MOHS, L. LILIUS, L. LANNFELT & J.P. BLASS. 1999. Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population. Ann. Neurol. 45: 48-53.
84. 84. SHEU, K.-F.R., A.M. BROWN, B.S. KRISTAL, R.N. KALARIA, L. LILIUS, L. LANNFELT & J.P. BLASS. A DLST genotype associated with reduced risk for Alzheimer's Disease. Neurology 1999; 52: 1505-1507.
85. 85. LILIUS, L, K.-F.R. SHEU, L. LANNFELT & J.P. BLASS. 1998. Association of DLST polymorphisms with familial Alzheimer's disease. Neurosci. Abstr. 24: 255.
86. 86. KUNUGI, H., S. NANKO, A. UEKI, K. ISSE & H. HIRASAWA. 1998. DLST gene and Alzheimer's disease. Lancet 351: 1584-1585.
87. 87. CRUTS, M., C.M. VAN DUIJN, H. BACKHOVENS, M. VAN DEN BROECK, A. WEHNERT, S. SERNEELS, R. SHERRINGTON, M. HUTTON, J. HARDY, P.H. ST. GEORGE-HYSLOP, A. HOFMAN & C. VAN BROECKHOVEN. 1998. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum. Mol. Genet. 7: 43-45.
88. 88. BEAL, M.F. 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366: 211-223.
89. 89. GIBSON, G.E., L.C.H. PARK, H. ZHANG, S. SORBI & N.Y. CALINGASAN. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann. N.Y. Acad. Sci. In press.
90. 90. GARDNER, P.R., I. RAINERE, L.B. EPSTEIN & C.W. WHITE. 1995. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270: 13399-13405.
91. 91. MULLER, H.F., F. ENGELSMANN, N.P. NAIR & Y. ROBITAILLE. 1997. Psychogeriatric clinical,electro-encephalographic and autopsy findings. Neuropsychobiology 35(2): 95-101.
92. 92. DE PEDIS, G., K. HEDNER, B.W. JOHANSSON & B. STEEN. 1987. Cardiac arrhythmia in geriatric patients with organic dementia. Compr. Gerontol. Sect. A, Clin. Lab. Sci. 1:115-117.
93. 93. MARIN, D.B., B. BREUER, M.L. MARIN, J. SILVERMAN, J. SCHMEIDLER, D. GREENBERG, S. FLYNN, M. MARE, M. LANTZ, L. LIBOW, R. NEUFELD, L. ALTSTIEL, K.L. DAVIS & R.C. MOHS. 1998. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 140:173-180.
94. 94. SPARKS, D.L. 1997. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N.Y. Acad. Sci. 826: 128-146.
95. 95. TRAYSTMAN, R.J., J.R. KIRSCH & R.C. KOEHLER. 1991. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1185-1195.
96. 96. DUNCAN, A.K., J. VITTONE, K.C. FLEMING & H.C. SMITH. 1996. Cardiovascular disease in elderly patients. Mayo Clin. Proc. 71: 184-196.
97. 97. BUEE, L., P.R. HOF & A. DELACOURTE. 1997. Brain microvascular changes in Alzheimer's disease and other dementias. Ann. N.Y. Acad. Sci. 826: 7-24.
98. 98. KALARIA, R.N. 1997. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 263-271.
99. 99. SIMPSON, I.A., K.R. CHUNDU, T. DAVIES-HILL, W.G. HONER & P. DAVIES. 1994. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35: 546-551.
100. 100. NATTE, R., H.V. VINTERS, M.L. MAAT-SCHIEMAN, M. BORNEBROEK, J. HAAN, R.A. Roos & S.G. VAN DUINEN. 1998. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Stroke 29: 1588-1594.
101. 101. MAMIYA, K., I. IEIRI, J. SHIMAMOTO, E. YUKAWA, J. IMAI, H. NINOMIYA, H. YAMADA, K. OTSUBO, S. HIGUCHI & M. TASHIRO. 1998. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia 39: 1317-1323.
102. 102. LINDER, M.W., R.A. PROUGH & R. VALDES, JR. 1997. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency. Clin. Chem. 43: 254-266.
103. 103. EPSTEIN, C.J. Phenotypes of Cu,Mn-SOD transgenic mice. Ann. N.Y. Acad. Sci. In press.
104. 104. VOLPE, B.T. & C.K. PETITO. 1985. Dementia with bilateral medial temporal lobe ischemia. Neurology 35: 1793-1797.
105. 105. SZE, C.-I., J.C. TRONCOSO, C. KAWAS, P. MOUTON, D.L. PRICE & L.J. MARTIN. 1997. Loss of the presynaptic vesicle protein synaptophysin correlates with cognitive decline in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 8: 933-934.
106. 106. COREY-BLOOM, J., M.N. SABBAGH, M.W. BONDI, L. HANSEN, M.F. ALFORD, E. MASLIAH & L.J. THAL. 1997. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 48:154-160.
107. 107. BLASS, J.P., K.A. NOLAN, R.S. BLACK & A. KURITA. 1992. Delirium: phenomenology and diagnosis - A neurobiological view. Int. Psychogeriatr. 3: 121-134.
108. 108. BLASS, J.P. & G.E. GIBSON. Cerebrometabolic aspects of delirium in relationship to dementia. Dementia Other Cogn. Disord. In press.
109. 109. BLASS, J.P., H.-M. HUANG & G.B. FREEMAN. 1992. The cellular basis of delirium and its relevance to age related disorders including Alzheimer's disease. Int. Psychogeriatr. 3: 373-396.
110. 110. FREEMAN, G.B. & G.E. GIBSON. 1988. Dopamine, acetylcholine and glutamate interactions in aging: behavioral and biochemical correlates. Ann. N.Y. Acad. Sci. 515: 191-202.
111. 111. TERRY, R.D., E. MASLIAH, D.P. SALMON, N. BUTTERS, R. DETERESA, R. HILL, L.A. HANSEN & R. KATZMAN. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30: 572-580.
112. 112. MCBEAN, D.E. & P.A. KELLY. 1998. Rodent models of global cerebral ischemia: a comparison of two-vessel occlusion and four-vessel occlusion. Gen. Pharmacol. 30: 431-434.
113. 113. CALINGASAN, N.Y. & G.E. GIBSON. 1999. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann. N.Y. Acad. Sci. In press.
114. 114. CALINGASAN, N.Y., W.J. CHUN, L.C.H. PARK, K. UCHIDA & G.E. GIBSON. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J. Neuropathol. Exp. Neurol. In press.
115. 115. HARDY, J., K. DUFF, K.G. HARDY, J. PEREZ-TUR & M. HUTTON. 1998. Genetic dissection of Alzheimer'sdisease and related dementias: amyloid and its relationship to tau. Nature Neurosci. 1: 355-358.
116. 116. JENDROSKA, K., O.M. HOFFMANN & S. PATT. 1997. Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann. N.Y. Acad. Sci. 826: 401-405.
117. 117. CALIGNASAN, N.Y, S.E. GANDY, H. BAKER, K.-F. SHEU, J.D. SMITH, B.T. LAMB, J.D. GEARHART, J.D. BUXBAUM, C. HARPER, D.J. SELKOE, D.L. PRICE, S.S. SISODIA & G.E. GIBSON. 1996. Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am. J. Pathol. 149: 1063-1071.
118. 118. BEYREUTHER, K., P. POLLWEIN, G. MULTHAUP, U. MONNING, G. KONIG, T. DYRKS, W. SCHUBERT & C.L. MASTERS. 1993. Regulation and expression of the Alzheimer's beta/A4 amyloid /A4 amyloid precursor protein in health, disease, and Down's syndrome. Ann, N.Y. Acad. Sci. 695: 91-102.
119. 119. YATIN, S.M., M. YATIN, T. AULICK, K.B. AIN & D.A. BUTTERFIELD. 1999. Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci. Lett. 263:17-20.
120. 120. Guo, Q., L. SEBASTIAN, B.L. SOPHER, M.W. MILLER, C.B. WARE, G.M. MARTIN & M.P. MATTSON. 1999. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72: 1019-1029.
121. 121. DIKALOV, S.I., M.P. VITEK, K.R. MAPLES & R.P. MASON. 1999. Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274: 9392-9399.
122. 122. BRUCE-KELLER, A.J., J.G. BEGLEY, W. FU, D.A. BUTTERFIELD, D.E. BREDESEN, J.B. HUTCHINS, K. HENSLEY & M.P. MATTSON. 1998. Bcl-2 protects isolated plasma and mitochondria! membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J. Neurochem. 70: 31-39.
123. 123. IADECOLA, C., F. ZHANG, K. NIWA, C. ECKMAN, S.K. TURNER, E. FISCHER, S. YOUNKIN, D.R. BORCHELT, K.K. HSIAO & G.A. CARLSON. 1999. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nature Neurosci. 2: 157-161.
124. 124. SUBRAMANIAM, R., T. KOPPAL, M. GREEN, S. YATIN, B. JORDAN, J. DRAKE & D.A. BUTTERFIELD. 1998. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23:1403-1410.
125. 125. MULTHAUP, G. & C.L. MASTERS. 1999. Metal binding and radical generation of proteins in human neurological diseases and aging. Metal Ions Biol. Systems 36: 365-387.
126. 126. BLASS, J.P., G.E. GIBSON & S. HOYER. 1997. Metabolism of the aging brain. In The Aging Brain. M.P. Mattson, J.W. Geddes, P. Tamiras, E.E. Bittar, Eds.: 109-128. JAI Press. London.